1. Home
  2. IRWD vs TK Comparison

IRWD vs TK Comparison

Compare IRWD & TK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.22

Market Cap

663.6M

Sector

Health Care

ML Signal

HOLD

Logo Teekay Corporation

TK

Teekay Corporation

HOLD

Current Price

$11.48

Market Cap

937.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRWD
TK
Founded
1998
1973
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
663.6M
937.1M
IPO Year
2009
1995

Fundamental Metrics

Financial Performance
Metric
IRWD
TK
Price
$3.22
$11.48
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$7.67
N/A
AVG Volume (30 Days)
2.6M
621.6K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
15.21%
EPS Growth
1400.00
N/A
EPS
0.24
N/A
Revenue
$298,276,000.00
N/A
Revenue This Year
$57.95
N/A
Revenue Next Year
$4.39
N/A
P/E Ratio
$13.67
$13.43
Revenue Growth
8.88
N/A
52 Week Low
$0.56
$7.12
52 Week High
$5.78
$14.38

Technical Indicators

Market Signals
Indicator
IRWD
TK
Relative Strength Index (RSI) 33.46 34.56
Support Level $3.02 $9.11
Resistance Level $3.95 $14.12
Average True Range (ATR) 0.19 0.49
MACD -0.07 -0.24
Stochastic Oscillator 1.18 7.80

Price Performance

Historical Comparison
IRWD
TK

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

Share on Social Networks: